Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

Long-term, heavy ketamine use is associated with memory problems, depression and anxiety. The drug may also cause gastrointestinal problems, abdominal pain popularly known as “k-cramps” and uropathy, ...

The phase 2b dose optimization study that prompted the ... this in other successful psychotropic drug applications, such as esketamine. Another problem cited in Lykos’ trials was a lack of ...

But there's no denying that it's seen a surge of interest in recent years. Ketamine clinics—or treatment centers that offer infusions of the drug—have popped up all over the country, not to mention on ...

Our favourite reality shows need a generous dose controversy to keep the audience engaged ... In 2019, America's Food and Drug Administration approved a nasal spray called esketamine, derived from ...

Patients were assigned to the esketamine or control group based on whether they received a subanaesthetic dose of esketamine. Primary and secondary outcome measures The primary outcome was extubation ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

Both esketamine and dexmedetomidine have been individually demonstrated to have the potential to enhance postoperative sleep quality. However, the effectiveness of mini-dose esketamine–dexmedetomidine ...

Results from the phase 2b trial are due later next year and according to Compass a single dose of COMP360 ... with Johnson & Johnson’s Spravato (esketamine) and a combination of olanzapine ...

A new systematic review published in the journal Cureus finds that psychedelic-assisted therapies such as ketamine, esketamine, and psilocybin may offer fast-acting and sustained relief for those with ...

In the new trial, called Study 501, a once-daily oral dose of Caplyta or a matched placebo ... for its nasal spray antidepressant Spravato (esketamine) in 2019 for treatment-resistant depression ...